Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.

Sadeleştirilmiş öğe sayfası
dc.contributor.authorIsik, Ulas
dc.contributor.authorKostek, Osman
dc.contributor.authorDemiray, Gokcen
dc.contributor.authorDirican, Ahmet
dc.contributor.authorSimsek, Melih
dc.contributor.authorBuyuksimsek, Mahmut
dc.contributor.authorUcar, Gokhan
dc.contributor.authorGunaydin, Ulug Mutlu
dc.contributor.authorSakalar, Teoman
dc.contributor.authorAliyev, Altay
dc.contributor.authorDemir, Atakan
dc.contributor.authorTurhal, Serdar
dc.contributor.authorPilanci, Kezban Nur
dc.contributor.authorKefeli, Umut
dc.contributor.authorGokyer, Ali
dc.contributor.authorPaydas, Semra
dc.contributor.authorUncu, Dogan
dc.contributor.authorOkten, Ilker Nihat
dc.contributor.authorUygun, Kazim
dc.contributor.authorCabuk, Devrim
dc.date.accessioned2025-10-16T15:23:49Z
dc.date.issued2019
dc.description.abstractAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, MAY 31-JUN 04, 2019
dc.identifier.doi10.1200/JCO.2019.37.15\_suppl.e16075
dc.identifier.otherWOS:000487345801503
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8019
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.sourceJOURNAL OF CLINICAL ONCOLOGY
dc.titleReal life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS